Function and molecular mechanisms of neuroendocrine cells in prostate cancer

Jiaoti Huang, Chengyu Wu, P. Anthony Di Sant'Agnese, Jorge L. Yao, Liang Cheng, Yanqun Na

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Benign prostate contains luminal epithelial cells, basal cells and a minor component of neuroendocrine cells whose function may be to regulate the growth, differentiation and secretory function of the prostate gland. Neuroendocrine (NE) cells are also present in prostate cancer (PC), and many studies have shown that their number increases in high-grade and high-stage tumors, particularly in hormonally treated and hormone-refractory (androgen independent) PC. Unlike the non-neuroendocrine secretory-type PC cells, NE cells lack androgen receptor and are likely androgen independent. Therefore it is conceivable that hormonal therapy for advanced or metastatic prostate cancer, which consists of inhibiting androgen production or blocking androgen function, will not eliminate NE cancer cells. Instead, these cells may be enriched after the therapy and they may establish paracrine networks to stimulate androgen-independent proliferation of PC, leading to tumor recurrence. This article reviews the major functions of NE cells in PC, including stimulation of cancer proliferation and invasion, apoptosis resistance and angiogenesis. It also discusses molecular pathways involved in NE differentiation and the effectors of the NE cells.

Original languageEnglish
Pages (from-to)128-138
Number of pages11
JournalAnalytical and Quantitative Cytology and Histology
Volume29
Issue number3
StatePublished - Jun 2007

Fingerprint

Neuroendocrine Cells
Prostatic Neoplasms
Androgens
Prostate
Neoplasms
Androgen Receptors
Epithelial Cells
Hormones
Apoptosis
Recurrence
Therapeutics
Growth

Keywords

  • Androgen independence
  • Hormonal therapy
  • Neuroendocrine differentiation
  • Prostate cancer

ASJC Scopus subject areas

  • Anatomy
  • Histology
  • Cell Biology

Cite this

Function and molecular mechanisms of neuroendocrine cells in prostate cancer. / Huang, Jiaoti; Wu, Chengyu; Di Sant'Agnese, P. Anthony; Yao, Jorge L.; Cheng, Liang; Na, Yanqun.

In: Analytical and Quantitative Cytology and Histology, Vol. 29, No. 3, 06.2007, p. 128-138.

Research output: Contribution to journalArticle

Huang, J, Wu, C, Di Sant'Agnese, PA, Yao, JL, Cheng, L & Na, Y 2007, 'Function and molecular mechanisms of neuroendocrine cells in prostate cancer', Analytical and Quantitative Cytology and Histology, vol. 29, no. 3, pp. 128-138.
Huang, Jiaoti ; Wu, Chengyu ; Di Sant'Agnese, P. Anthony ; Yao, Jorge L. ; Cheng, Liang ; Na, Yanqun. / Function and molecular mechanisms of neuroendocrine cells in prostate cancer. In: Analytical and Quantitative Cytology and Histology. 2007 ; Vol. 29, No. 3. pp. 128-138.
@article{5a5914fa550b42918ae47afa4196ba7f,
title = "Function and molecular mechanisms of neuroendocrine cells in prostate cancer",
abstract = "Benign prostate contains luminal epithelial cells, basal cells and a minor component of neuroendocrine cells whose function may be to regulate the growth, differentiation and secretory function of the prostate gland. Neuroendocrine (NE) cells are also present in prostate cancer (PC), and many studies have shown that their number increases in high-grade and high-stage tumors, particularly in hormonally treated and hormone-refractory (androgen independent) PC. Unlike the non-neuroendocrine secretory-type PC cells, NE cells lack androgen receptor and are likely androgen independent. Therefore it is conceivable that hormonal therapy for advanced or metastatic prostate cancer, which consists of inhibiting androgen production or blocking androgen function, will not eliminate NE cancer cells. Instead, these cells may be enriched after the therapy and they may establish paracrine networks to stimulate androgen-independent proliferation of PC, leading to tumor recurrence. This article reviews the major functions of NE cells in PC, including stimulation of cancer proliferation and invasion, apoptosis resistance and angiogenesis. It also discusses molecular pathways involved in NE differentiation and the effectors of the NE cells.",
keywords = "Androgen independence, Hormonal therapy, Neuroendocrine differentiation, Prostate cancer",
author = "Jiaoti Huang and Chengyu Wu and {Di Sant'Agnese}, {P. Anthony} and Yao, {Jorge L.} and Liang Cheng and Yanqun Na",
year = "2007",
month = "6",
language = "English",
volume = "29",
pages = "128--138",
journal = "Analytical and Quantitative Cytopathology and Histopathology",
issn = "0301-102X",
publisher = "John Rylands University Library",
number = "3",

}

TY - JOUR

T1 - Function and molecular mechanisms of neuroendocrine cells in prostate cancer

AU - Huang, Jiaoti

AU - Wu, Chengyu

AU - Di Sant'Agnese, P. Anthony

AU - Yao, Jorge L.

AU - Cheng, Liang

AU - Na, Yanqun

PY - 2007/6

Y1 - 2007/6

N2 - Benign prostate contains luminal epithelial cells, basal cells and a minor component of neuroendocrine cells whose function may be to regulate the growth, differentiation and secretory function of the prostate gland. Neuroendocrine (NE) cells are also present in prostate cancer (PC), and many studies have shown that their number increases in high-grade and high-stage tumors, particularly in hormonally treated and hormone-refractory (androgen independent) PC. Unlike the non-neuroendocrine secretory-type PC cells, NE cells lack androgen receptor and are likely androgen independent. Therefore it is conceivable that hormonal therapy for advanced or metastatic prostate cancer, which consists of inhibiting androgen production or blocking androgen function, will not eliminate NE cancer cells. Instead, these cells may be enriched after the therapy and they may establish paracrine networks to stimulate androgen-independent proliferation of PC, leading to tumor recurrence. This article reviews the major functions of NE cells in PC, including stimulation of cancer proliferation and invasion, apoptosis resistance and angiogenesis. It also discusses molecular pathways involved in NE differentiation and the effectors of the NE cells.

AB - Benign prostate contains luminal epithelial cells, basal cells and a minor component of neuroendocrine cells whose function may be to regulate the growth, differentiation and secretory function of the prostate gland. Neuroendocrine (NE) cells are also present in prostate cancer (PC), and many studies have shown that their number increases in high-grade and high-stage tumors, particularly in hormonally treated and hormone-refractory (androgen independent) PC. Unlike the non-neuroendocrine secretory-type PC cells, NE cells lack androgen receptor and are likely androgen independent. Therefore it is conceivable that hormonal therapy for advanced or metastatic prostate cancer, which consists of inhibiting androgen production or blocking androgen function, will not eliminate NE cancer cells. Instead, these cells may be enriched after the therapy and they may establish paracrine networks to stimulate androgen-independent proliferation of PC, leading to tumor recurrence. This article reviews the major functions of NE cells in PC, including stimulation of cancer proliferation and invasion, apoptosis resistance and angiogenesis. It also discusses molecular pathways involved in NE differentiation and the effectors of the NE cells.

KW - Androgen independence

KW - Hormonal therapy

KW - Neuroendocrine differentiation

KW - Prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=34250899095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250899095&partnerID=8YFLogxK

M3 - Article

C2 - 17672372

AN - SCOPUS:34250899095

VL - 29

SP - 128

EP - 138

JO - Analytical and Quantitative Cytopathology and Histopathology

JF - Analytical and Quantitative Cytopathology and Histopathology

SN - 0301-102X

IS - 3

ER -